1.

P687 Prevalence of iron deficiency and anaemia in the outpatient Inflammatory Bowel Disease population: a Dutch national cross-sectional study

1.

OP013. Evolution of corticosteroid use in Crohn’s disease patients between 1991 and 2014: results from the Dutch population-based Inflammatory Bowel Disease South Limburg cohort

1.

P505. The effect of using a question prompt list in outpatient clinic consultations in a Dutch inflammatory bowel disease population

1.

P622. In a Dutch real-life inflammatory bowel disease score cohort with 90% prior anti-tumour necrosis factor failure, vedolizumab showed a 25% remission rate: a retrospective mult...

1.

P662. Evolution of IBD incidence, disease phenotype, and mortality; 20 years of epidemiologic research in the Dutch population-based inflammatory bowel disease South Limburg cohort

1.

P732. Pooled resequencing of 122 ulcerative colitis genes in a large Dutch population suggests population-specific association of rare variants in MUC2

1.

DOP017 Patterns of anti-TNF use and associated treatment outcomes in inflammatory bowel disease patients: results from an analysis of Dutch health insurance claims data

1.

P716 Beta-blocker use is associated with a higher relapse risk of inflammatory bowel disease – a Dutch retrospective cohort study

1.

DOP034 Assessment of direct healthcare cost drivers of Crohn’s disease in a Dutch population-based cohort study shows a major shift

1.

P784 The direct healthcare costs of Crohn’s disease increased over the last two decades in a Dutch population-based cohort